Davenport & Co’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
SI
YIH
EA
KPP
HPC
HWAM
BP
SWM
1IA
FFA
Davenport & Co's IRMD Position: Q2 2026 in Review
Davenport & Co held its iRadimed (IRMD) position steady in Q2 2026 at 2,785 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.
Davenport & Co first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $268K in Q1 2026. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Davenport & Co held 2,785 shares of iRadimed worth $266K as of Q2 2026.
- Davenport & Co left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #1231 holding.
- Davenport & Co first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
- Davenport & Co's iRadimed position peaked at $268K in Q1 2026.
- 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.